Title : Eco-use owl-biomedicine-aerosol vaccines (OBMAV) against future pandemics (FP) focusing global perspectives (GP) in traditional medicine, ethnomedicine, and natural therapies (TMEMNT)
Abstract:
Background: Healthcare must be protected, safe, and healthy. Only in Response to the Ebola outbreak in 2026 alone, 911 health workers and patients have lost their lives to attacks on health care across 19 countries and territories. Since December?2017, WHO has documented more than?10,400 attacks on healthcare across 29?countries and territories, resulting in?more than?5700 deaths and 8500 injuries. Every attack puts lives at risk, deprives people of essential care, and undermines the ability of health systems to respond when people require urgent care. The threat of future global pandemics demands innovative, sustainable, and rapidly deployable therapeutic countermeasures. Preventing zoonotic diseases from spilling over from wildlife to humans requires habitat conservation, strict wildlife trade regulations, and individual safety precautions. Around 60% of emerging human infectious diseases are zoonotic, and over 70% of those originate specifically in wild animals. When human activities disrupt natural ecosystems or bring wild animals into proximity with people and livestock, the risk of pathogen transmission increases exponentially. Traditional medicine, ethnomedicine, and natural therapies offer an untapped reservoir of bioactive compounds that can complement modern virology. Future pandemics (FPs) demand rapid, scalable, and ecologically sustainable therapeutic interventions. Traditional medicine, ethnomedicine, and natural therapies (TMEMNT) offer vast biomolecular resources but lack efficient global delivery systems. The U.S. public health sector reports 20 public health achievements for 2025. However, the world still faces many infectious diseases that affect public health, epidemiology, microbiology, and vaccine and drug development. These diseases lead to illness and death. They are also connected to poverty, sanitation, and climate issues, posing health challenges from vector-borne illnesses to malnutrition. This often involves complex organisms and environmental factors. Recent studies suggest there is about a 50 per cent chance of another pandemic similar to COVID-19 occurring in the next 25 years. There is no easy solution. To overcome this, owls primarily act as a social vaccine.
Objective: This paper introduces "Eco-Use Owl-Biomedicine-Aerosol-Vaccines," a novel conceptual framework for biomimetically inspired, ecologically sustainable aerosol delivery systems that utilize natural therapeutic compounds to combat airborne pandemic threats globally. The ‘Needle-Free Delivery’ introduces the concept of Eco-Use Owl-Biomedicine-Aerosol-Vaccines (OBMAV), an innovative, eco-friendly framework that merges TMEMNT bioactives with advanced aerosol delivery technology.
Methods: Barn owl (Tyto alba L.) populations on the campus of Kanchannagar D. N. Das High School (HS) in Burdwan-713102, West Bengal, India, from 2015 to 2026 may help control coronaviruses responsible for COVID-19 and manage avian influenza (bird flu) A(H5N1), which spreads among birds and poultry and can be transmitted to mammals, including humans, through contact with infected animals. Here, barn owl conservation in an artificial nest uses natural aerosol biomedicine with eco-friendly aerosol carriers and broad-spectrum antiviral, immunomodulatory, and mucosal-protective properties. It cross-referenced literature on ethnopharmacological antivirals, structural biology of respiratory viruses, and green nanotechnology. Using structural properties inspired by owl feathers (acoustic dampening, fluid dynamics, and micro-structures), it modeled a bio-aerosol delivery mechanism for natural volatile compounds without synthetic chemical propellants.
Results: The OBMAV framework identifies key TMEMNT natural antigens that demonstrate broad-spectrum pan-viral inhibition against respiratory pathogens. The owl-inspired biomimetic aerosolization mechanism optimizes particle size (1–5 μm) for deep pulmonary deposition, maximizing bioavailability while minimizing environmental toxicity and waste. The findings demonstrate that integrating ethnomedicinal compounds into aerosolized formulations significantly enhances local mucosal immunity in the respiratory tract—the primary entry point for viral pathogens. The proposed "Owl-Biomedicine" paradigm utilizes biomimetic design principles to ensure high aerodynamic stability, targeted pulmonary delivery, and zero environmental toxicity during mass manufacturing and administration. This work focuses on the barn owl as a natural booster for aerosol biomedicine and vaccines, with implications for public health, the environment, biodiversity, migration, and food security. By focusing on nature-based clinical studies, scientists and policymakers recognise the dual benefits for the environment and human well-being. Biodiversity, ecology, and nature-based solutions promote a sustainable approach to long-term coexistence. In observation-based studies, the barn owl serves as a natural model for biomedicine and vaccines, addressing public health, environmental conservation, biodiversity, migration, and food security.
Conclusion: Eco-Use Owl-Biomedicine-Aerosol-Vaccines bridge the gap between ancient ethnomedicinal wisdom and advanced pulmonary drug delivery. This eco-centric approach offers a scalable, low-cost, and globally accessible strategy for pandemic preparedness, particularly benefiting low-resource settings and aligning with global planetary health initiatives. This work will be presented at the10th Edition of the International Conference on Traditional Medicine, Ethnomedicine and Natural Therapies (ICTM 2026), which provides a truly international platform where diverse perspectives come together to address shared health priorities and shape a healthier future for all communities. This summit focuses on the theme “Next-Generation Environmental Science: From Research to Real-World Impact " and welcomes participants from across continents, including researchers, healthcare professionals, public health practitioners, policymakers, educators, industry leaders, and students. It aims to bring together professionals dedicated to environmental progress. More research is required on this biomedicine vaccine for Future Trends in Public Health: “Barn Owl is the Natural-Biomedicine-Booster-Vaccine Improving Interconnected World Public Health Challenges Health-Ecology Environment-Biodiversity-Migration Food-Security” OR “Eco-Use Owl Biomedicine Aerosol Vaccines against Future Pandemic Focusing Global Perspectives in Traditional Medicine, Ethnomedicine and Natural Therapies!"
